A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression
暂无分享,去创建一个
[1] C. Glass,et al. Nuclear receptor coactivators. , 2000, Advances in pharmacology.
[2] M. Lazar,et al. A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor γ-activating Properties* , 1998, The Journal of Biological Chemistry.
[3] S. Minucci,et al. Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.
[4] C. Glass,et al. ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors , 1998, Molecular and Cellular Biology.
[5] M. Lazar,et al. Interdomain communication regulating ligand binding by PPAR-γ , 1998, Nature.
[6] L. Jendeberg,et al. Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ* , 1998, The Journal of Biological Chemistry.
[7] R J Fletterick,et al. Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.
[8] M. Privalsky,et al. Transcriptional Silencing Is Defined by Isoform- and Heterodimer-Specific Interactions between Nuclear Hormone Receptors and Corepressors , 1998, Molecular and Cellular Biology.
[9] D. Robyr,et al. Transcriptional Regulatory Patterns of the Myelin Basic Protein and Malic Enzyme Genes by the Thyroid Hormone Receptors α1 and β1* , 1998, The Journal of Biological Chemistry.
[10] C. Glass,et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators , 1998, Nature.
[11] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[12] K. Struhl,et al. Targeted Recruitment of the Sin3-Rpd3 Histone Deacetylase Complex Generates a Highly Localized Domain of Repressed Chromatin In Vivo , 1998, Molecular and Cellular Biology.
[13] T. Hoshino,et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] R J Fletterick,et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. , 1998, Science.
[15] R. Heyman,et al. Transactivation by Retinoid X Receptor–Peroxisome Proliferator-Activated Receptor γ (PPARγ) Heterodimers: Intermolecular Synergy Requires Only the PPARγ Hormone-Dependent Activation Function , 1998, Molecular and Cellular Biology.
[16] P B Sigler,et al. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] K.,et al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Inoue,et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.
[19] T. Tagami,et al. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone. , 1998, Endocrinology.
[20] C. Glass,et al. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Lazar,et al. Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression , 1997, Molecular and cellular biology.
[22] M. Privalsky,et al. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release , 1997, Molecular and cellular biology.
[23] S. Schreiber,et al. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. , 1997, Current opinion in chemical biology.
[24] P. Chambon,et al. A mutation mimicking ligand‐induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers , 1997, The EMBO journal.
[25] V. Chatterjee,et al. Thyroid Hormone-mediated Enhancement of Heterodimer Formation between Thyroid Hormone Receptor β and Retinoid X Receptor* , 1997, The Journal of Biological Chemistry.
[26] S. Schreiber,et al. Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.
[27] L. Chin,et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.
[28] C. Glass,et al. A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.
[29] M. Lazar,et al. Stoichiometric and steric principles governing repression by nuclear hormone receptors. , 1997, Genes & development.
[30] R. Evans,et al. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. , 1997, Genes & development.
[31] G. Jenster,et al. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. , 1997, Recent progress in hormone research.
[32] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[33] D. Moore,et al. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. , 1996, Molecular endocrinology.
[34] D. Moras,et al. LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA , 1996 .
[35] C. Glass,et al. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains , 1996, Molecular and cellular biology.
[36] Jacek Ostrowski,et al. Two distinct actions of retinoid-receptor ligands , 1996, Nature.
[37] K. Umesono,et al. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Privalsky,et al. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. , 1996, Molecular endocrinology.
[39] R. Evans,et al. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states , 1996, Molecular and cellular biology.
[40] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[41] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.
[42] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[43] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.
[44] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[45] Myles Brown,et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor , 1995, Nature.
[46] Thorsten Heinzel,et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.
[47] R. Evans,et al. A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.
[48] P. Sigler,et al. Structural determinants of nuclear receptor assembly on DNA direct repeats , 1995, Nature.
[49] K. Umesono,et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.
[50] P. Chambon,et al. RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.
[51] B M Raaka,et al. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation , 1995, Molecular and cellular biology.
[52] B. O’Malley,et al. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region , 1995, Molecular and cellular biology.
[53] B. O’Malley,et al. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing , 1995, Molecular and cellular biology.
[54] D. Moore,et al. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.
[55] R. Renkawitz,et al. Two silencing sub-domains of v-erbA synergize with each other, but not with RXR. , 1994, Nucleic acids research.
[56] M. Parker,et al. Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[57] G. Martin,et al. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.
[58] P. Chambon,et al. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. , 1994, EMBO Journal.
[59] D. Edwards,et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. , 1992, The Journal of biological chemistry.
[60] E. Appella,et al. H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. , 1992, The EMBO journal.
[61] R. Renkawitz,et al. A transferable silencing domain is present in the thyroid hormone receptor, in the v‐erbA oncogene product and in the retinoic acid receptor. , 1992, The EMBO journal.
[62] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[63] K. Umesono,et al. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.
[64] J. Harney,et al. Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. , 1989, The New biologist.
[65] M. Pfahl,et al. Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity , 1989, Nature.
[66] Klaus Damm,et al. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist , 1989, Nature.